Module

Current Treatment Options and the Need for Novel Therapeutics in Glioblastomas

Source: Current Research Directions in Glioblastoma Multiforme: Evolutions in Targeted Therapy

Current Treatment Options and the Need for Novel Therapeutics in Glioblastomas

Program Director: James J. Vredenburgh, MD

Faculty:

Patrick Y. Wen, MD

CME CREDIT INFORMATION

Release Date: 11/12/08

Expiration Date: 11/11/09

Physicians: maximum of 0.75 AMA PRA Category 1 Credits™

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Discuss current approaches to the treatment of GBM including chemotherapy, surgery, and radiotherapy
Recount research directions with targeted agents demonstrating investigational potential for the treatment of GBM
Cite genetic factors affecting the pathogenesis and prognosis of GBM
Explain challenges in the treatment of patients with recurrent GBM
Summarize considerations in the use of anticonvulsant therapy for patients with GBM

Topics covered include:

Genetic Factors in the Pathogenesis and Treatment of GBM
Surgery in the Management of GBM
Radiotherapy in the Treatment of GBM
Temozolomide in the Treatment of GBM
Therapeutic Approaches for Patients With Recurrent GBM
BCNU Wafers: An Alternative to Standard Adjuvant Chemotherapy
Controlling Brain Seizures in Patients With GBM
Conclusion

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.